NO20030946L - Medisinske sammensetninger - Google Patents

Medisinske sammensetninger

Info

Publication number: NO20030946L
Authority: NO; Norway
Prior art keywords: medical compositions; medical; compositions
Prior art date: 2000-09-01

Application number

NO20030946A

Other languages

English (en)

Other versions

NO20030946D0 (no

Inventor

Takafumi Kohama

Toshimori Inaba

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-01

Filing date

2003-02-28

Publication date

2003-04-08

2003-02-28 Application filed by Sankyo Co filed Critical Sankyo Co

2003-02-28 Publication of NO20030946D0 publication Critical patent/NO20030946D0/no

2003-04-08 Publication of NO20030946L publication Critical patent/NO20030946L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

NO20030946A 2000-09-01 2003-02-28 Medisinske sammensetninger NO20030946L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000265082		2000-09-01
PCT/JP2001/007438 WO2002020009A1 (fr)	2000-09-01	2001-08-29	Compositions medicales

Publications (2)

Publication Number	Publication Date
NO20030946D0 NO20030946D0 (no)	2003-02-28
NO20030946L true NO20030946L (no)	2003-04-08

Family

ID=18752403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030946A NO20030946L (no)	2000-09-01	2003-02-28	Medisinske sammensetninger

Country Status (17)

Country	Link
EP (1)	EP1314423A4 (no)
KR (1)	KR20030029871A (no)
CN (1)	CN1473042A (no)
AU (2)	AU8254101A (no)
BR (1)	BR0113523A (no)
CA (1)	CA2420951A1 (no)
CZ (1)	CZ2003593A3 (no)
HU (1)	HUP0301728A3 (no)
IL (1)	IL154414A0 (no)
MX (1)	MXPA03001857A (no)
NO (1)	NO20030946L (no)
NZ (1)	NZ524406A (no)
PL (1)	PL362244A1 (no)
RU (1)	RU2246302C2 (no)
SK (1)	SK2552003A3 (no)
WO (1)	WO2002020009A1 (no)
ZA (1)	ZA200301543B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0113523A (pt) *	2000-09-01	2004-06-29	Sankyo Co	Composição farmacêutica, kit, e, usos de n-(1-octil-5-carboxi-metil)-4,6-dimetil-indolin-7-il)-2,2-d imetil-propanamida ou um seu sal farmacologicamente aceitável, e de uma composição
KR20060111898A (ko)	2003-08-29	2006-10-30	교와 가부시키가이샤	지질-풍부-플라크의 안정화 방법 및 파열 예방방법
TW200619204A (en) *	2004-12-10	2006-06-16	Kowa Co	Method for reduction, stabilization and prevention of rupture of lipid rich plaque
RU2308947C1 (ru) *	2006-02-26	2007-10-27	Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН)	Лекарственное средство с гиполипидемическим эффектом "симваглизин"

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL112639A0 (en) *	1994-03-11	1995-05-26	Bristol Myers Squibb Co	A pharmaceutical composition containing pravastin
JP3720395B2 (ja) *	1994-09-20	2005-11-24	京都薬品工業株式会社	新規ヘテロ環誘導体、その製造方法およびその医薬用途
AU706628B2 (en) *	1995-07-03	1999-06-17	Sankyo Company Limited	Treatment of arteriosclerosis and xanthoma
DK0866059T3 (da) *	1995-10-05	2002-03-25	Kyoto Pharma Ind	Nye heterocykliske derivater og medicinsk anvendelse deraf
CN1217656C (zh) *	1995-11-02	2005-09-07	沃尼尔·朗伯公司	用于调节脂浓度的方法和药物组合物
KR100334567B1 (ko) *	1996-11-27	2002-05-03	디. 제이. 우드, 스피겔 알렌 제이	아포 비-분비/엠티피 억제성 아미드
WO1999021570A1 (en) *	1997-10-28	1999-05-06	Korea Institute Of Science And Technology	Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
HUP0102880A3 (en) *	1998-07-21	2002-11-28	Warner Lambert Co	Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
WO2001022962A1 (en) *	1999-09-30	2001-04-05	Merck & Co., Inc.	Anti-hypercholesterolemic drug combination
BR0113523A (pt) *	2000-09-01	2004-06-29	Sankyo Co	Composição farmacêutica, kit, e, usos de n-(1-octil-5-carboxi-metil)-4,6-dimetil-indolin-7-il)-2,2-d imetil-propanamida ou um seu sal farmacologicamente aceitável, e de uma composição

2001
- 2001-08-29 BR BR0113523-6A patent/BR0113523A/pt not_active IP Right Cessation
- 2001-08-29 AU AU8254101A patent/AU8254101A/xx active Pending
- 2001-08-29 CA CA002420951A patent/CA2420951A1/en not_active Abandoned
- 2001-08-29 SK SK255-2003A patent/SK2552003A3/sk not_active Application Discontinuation
- 2001-08-29 CN CNA018184723A patent/CN1473042A/zh active Pending
- 2001-08-29 AU AU2001282541A patent/AU2001282541B2/en not_active Ceased
- 2001-08-29 CZ CZ2003593A patent/CZ2003593A3/cs unknown
- 2001-08-29 RU RU2003105835/15A patent/RU2246302C2/ru not_active IP Right Cessation
- 2001-08-29 PL PL01362244A patent/PL362244A1/xx unknown
- 2001-08-29 MX MXPA03001857A patent/MXPA03001857A/es unknown
- 2001-08-29 WO PCT/JP2001/007438 patent/WO2002020009A1/ja not_active Application Discontinuation
- 2001-08-29 NZ NZ524406A patent/NZ524406A/en unknown
- 2001-08-29 KR KR10-2003-7002861A patent/KR20030029871A/ko not_active Withdrawn
- 2001-08-29 EP EP01961177A patent/EP1314423A4/en not_active Withdrawn
- 2001-08-29 IL IL15441401A patent/IL154414A0/xx unknown
- 2001-08-29 HU HU0301728A patent/HUP0301728A3/hu unknown
2003
- 2003-02-25 ZA ZA200301543A patent/ZA200301543B/en unknown
- 2003-02-28 NO NO20030946A patent/NO20030946L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0113523A (pt)	2004-06-29
PL362244A1 (en)	2004-10-18
AU2001282541B2 (en)	2004-06-24
ZA200301543B (en)	2004-06-09
RU2246302C2 (ru)	2005-02-20
CA2420951A1 (en)	2003-02-28
NZ524406A (en)	2004-06-25
CN1473042A (zh)	2004-02-04
AU8254101A (en)	2002-03-22
KR20030029871A (ko)	2003-04-16
EP1314423A4 (en)	2004-05-19
WO2002020009A1 (fr)	2002-03-14
HUP0301728A2 (hu)	2003-08-28
SK2552003A3 (en)	2003-08-05
HUP0301728A3 (en)	2004-05-28
MXPA03001857A (es)	2003-06-04
CZ2003593A3 (cs)	2003-05-14
IL154414A0 (en)	2003-09-17
EP1314423A1 (en)	2003-05-28
NO20030946D0 (no)	2003-02-28

Publication	Publication Date	Title
ATE303787T1 (de)	2005-09-15	Schergelzusammensetzungen
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
AR028197A1 (es)	2003-04-30	Composiciones antitranspirantes
DK1199054T3 (da)	2004-09-27	Væskefrakturhånddel
DK1317177T3 (da)	2004-12-20	Desinficerende formuleringer
IS2932B (is)	2015-12-15	Fúlvestrant samsetning
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO20026175L (no)	2003-02-26	Vaksinesammensetning
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
FI20010780A0 (fi)	2001-04-12	Parannetut koostumukset
DE60106275T8 (de)	2006-08-24	Dermatologische zusammensetzung
DE60125806D1 (de)	2007-02-15	Chirurgische spüleinrichtung
DE60137637D1 (de)	2009-03-26	Magnetorheologische fettzusammensetzung
DE60100567D1 (de)	2003-09-11	Antimikrobielle zusammensetzungen
AR028087A1 (es)	2003-04-23	Composiciones cosmeticas
ATE257691T1 (de)	2004-01-15	Schweisshemmende zusammensetzungen
ATE369830T1 (de)	2007-09-15	Schweisshemmende zusammensetzungen
ATE314049T1 (de)	2006-01-15	Schweisshemmende zusammensetzungen
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
NO20031095L (no)	2003-03-10	Farmasoytiske sammensetninger
DE60139896D1 (de)	2009-10-22	Ldenden zusammensetzungen
DE60116858D1 (de)	2006-04-13	Zusammensetzung
DE60142401D1 (de)	2010-07-29	Verbindungsverfahren
AR027959A1 (es)	2003-04-16	Composiciones cosmeticas

Legal Events

Date	Code	Title	Description
2007-02-19	FC2A	Withdrawal, rejection or dismissal of laid open patent application